We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$6.18B
Cap. Flow %
-1.26%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,371
Increased
4,862
Reduced
5,559
Closed
1,866

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.23%
2 Technology 2.7%
3 Consumer Discretionary 1.66%
4 Financials 1.18%
5 Communication Services 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBCP icon
11026
Concrete Pumping Holdings
BBCP
$475M
$83.3K ﹤0.01%
10,379
-14,010
-57% -$98.7K
MRCC
11027
DELISTED
Monroe Capital Corp
MRCC
$83.2K ﹤0.01%
+10,176
New +$78.3K
ORKA
11028
CALL
Oruka Therapeutics
ORKA
$6.39B
$83.2K ﹤0.01%
3,417
-800
-19% -$19.7K
BPT
11029
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$83.2K ﹤0.01%
+18,251
New +$110K
EMBK
11030
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$83K ﹤0.01%
29,037
-46,055
-61% -$129K
NUVB icon
11031
Nuvation Bio
NUVB
$2.45B
$83K ﹤0.01%
46,103
-72,456
-61% -$123K
BDN
11032
CALL
Brandywine Realty Trust
BDN
$534M
$82.8K ﹤0.01%
17,800
-11,300
-39% -$46.1K
NHTC icon
11033
PUT
Natural Health Trends
NHTC
$14.7M
$82.7K ﹤0.01%
15,100
-3,600
-19% -$19.7K
ALTI icon
11034
AlTi Global
ALTI
$456M
$82.7K ﹤0.01%
10,798
-245,631
-96% -$1.72M
HTT
11035
PUT
High Templar Tech Ltd
HTT
$413M
$82.6K ﹤0.01%
41,300
-21,000
-34% -$30.3K
PSTX
11036
CALL
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$82.4K ﹤0.01%
+46,800
New +$120K
HBIO icon
11037
CALL
Harvard Bioscience
HBIO
$36M
$82.3K ﹤0.01%
+1,500
New +$82.3K
BSBK icon
11038
Bogota Financial
BSBK
$116M
$82.2K ﹤0.01%
10,068
-3,393
-25% -$28.7K
EVTL icon
11039
Vertical Aerospace
EVTL
$127M
$81.9K ﹤0.01%
4,156
-586
-12% -$11.1K
NEWP
11040
PUT
New Pacific Metals
NEWP
$1.37B
$81.8K ﹤0.01%
37,500
-19,400
-34% -$47.5K
MOR
11041
PUT
DELISTED
MorphoSys AG American Depositary Shares
MOR
$81.4K ﹤0.01%
+10,900
New +$66.3K
RJET
11042
PUT
Republic Airways Holdings
RJET
$861M
$81.3K ﹤0.01%
2,127
-513
-19% -$15.7K
INZY
11043
CALL
DELISTED
Inozyme Pharma
INZY
$81.3K ﹤0.01%
14,600
-4,900
-25% -$29K
MCR
11044
DELISTED
MFS Charter Income Trust
MCR
$81.2K ﹤0.01%
12,875
-7,152
-36% -$44.4K
DHY
11045
Credit Suisse High Yield Credit Fund
DHY
$236M
$81.1K ﹤0.01%
+42,935
New +$81.4K
RHE
11046
DELISTED
Regional Health Properties, Inc.
RHE
$81.1K ﹤0.01%
22,536
-8,475
-27% -$28.4K
CMPX icon
11047
Compass Therapeutics
CMPX
$454M
$81.1K ﹤0.01%
25,507
-757,110
-97% -$2.38M
NM
11048
DELISTED
Navios Maritime Holdings Inc.
NM
$81.1K ﹤0.01%
+49,422
New +$86.9K
TCRT icon
11049
PUT
Alaunos Therapeutics
TCRT
$4.22M
$80.9K ﹤0.01%
1,058
+307
+41% +$24.8K
KLRS
11050
Kalaris Therapeutics
KLRS
$97.6M
$80.8K ﹤0.01%
1,033
+308
+42% +$29.3K

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.